Unfortunately it's very low on their priorities. Big Pharma is all about $$$, and R&D for antibiotics is not very profitable. They're more interested in developing meds for chronic ailments which people become dependent/reliant on (antidepressants, statins etc), not those that people usually take a single course of for a cure.Maybe this will push big pharmaceuticals to hurry up with new antibiotics that are still in trials